Circular dichroism spectra of ruthenium bipyridine complexes, .DELTA.-[Ru(bpy)3]2+/+/0/-

H/D solvent isotope effects on the photoracemization reaction of enantiomeric the tris(2,2′-bipyridine)ruthenium(ii) complex and its analogues

This work assessed solvent isotope effects on the photoracemization rate and emission lifetime for [Ru(bpy)₃]²⁺ (bpy = 2,2′-bipyridine) in water.

Use of a Compact Tripodal Tris(bipyridine) Ligand to Stabilize a Single-Metal-Centered Chirality: Stereoselective Coordination of Iron(II) and Ruthenium(II) on a Semirigid Hexapeptide Macrocycle

Fe(II)-coordinating hexapeptides containing three 2,2'-bipyridine moieties as side chains were designed and synthesized. A cyclic hexapeptide having three [(2,2'-bipyridin)-5-yl]-d-alanine (d-Bpa5) residues, in which d-Bpa5 and Gly are alternately arranged with 3-fold rotational symmetry, coordinated with Fe(II) to form a 1:1 octahedral Fe(II)-peptide complex with a single facial-Λ configuration of the metal-centered chirality. NMR spectroscopy and molecular dynamics simulations revealed that the Fe(II)-peptide complex has an apparent C₃-symmetric conformations on the NMR time scale, while the peptide backbone is subject to dynamic conformational exchange between three asymmetric β/γ conformations and one C₃-symmetric γ/γ/γ conformation. The semirigid cyclic hexapeptide preferentially arranged these conformations of the small octahedral Fe(II)-bipyridine complex, as well as the Ru(II) congener, to underpin the single configuration of the metal-centered chirality.

A ruthenium(II) tris(bipyridyl) amino acid: synthesis and direct incorporation into an alpha-helical peptide by solid-phase synthesis

The synthesis of a ruthenium(II) tris(bipyridyl) amino acid is described along with its incorporation into a helix-forming peptide using standard solid-phase peptide synthesis methods. The physical properties of the metalloamino acid separately and in the context of the peptide are reported. The electrochemical potential, absorption spectrum, emission and excitation spectra, and emission lifetime data for the ruthenium(II) tris(bipyridyl) amino acid are similar to those of ruthenium(II) tris(bipyridine), indicating that the amino acid functionality introduced on one of the bipyridine rings does not strongly perturb the properties of the metal complex. The ruthenium(II) tris(bipyridyl) amino acid is amenable to direct incorporation into a synthetic peptide using solid-phase methods and BOC/benzyl chemistry. The 22 amino acid alanine-based peptide produced is 67% helical at 0 degrees C in aqueous buffer, as measured by circular dichroism spectroscopy. The 2,2,2-trifluorethanol helix induction curve and the temperature dependence of the helicity are typical for alanine-based peptides. The Lifson-Roig helix propagation parameter, w, derived from circular dichroism and NMR-monitored kinetic hydrogen-deuterium exchange is 0.5 +/- 0.1 at 0 degrees C, indicating a moderate helix propensity for this metalloamino acid.

Octahedral Complexes with Predetermined Helical Chirality: Xylene-Bridged Bis([4,5]-pineno-2,2'-bipyridine) Ligands (Chiragen[o-, m-, p-xyl]) with Ruthenium(II)

Tetradentate ligands are obtained by joining two optically active [4,5]-pineno-2,2'-bipyridine molecules in a stereoselective reaction, where two new stereogenic centers are created. These ligands are new members of the chiragen family that form OC-6 complexes with predetermined helical chirality. Ru(II) complexes with 4,4'-dimethyl-2,2'-bipyridine occupying the remaining coordination sites have been synthesized with all three new ligands. Characterization of the ruthenium complexes by NMR spectroscopy confirm C(2)-symmetric structures in solution. CD spectra show that the complexes are composed of only one helical diastereomer with the expected absolute configurations. In addition, a strong chiral amplification is observed, if precursors of low enantiomeric purity are used. This is due to the inability of ligands that are heterochiral in the two bpy moieties to coordinate to one center. X-ray structural data were obtained for the complex Delta-[RuCG[o-xyl](4,4'-DMbpy)](PF(6))(2). Crystal data (Mo Kalpha, 298 K): trigonal, space group R3, a = 52.986(4) Å, c = 10.545(1) Å, V = 25639(4) Å(3), Z = 18, R1 = 0.087, and wR2 = 0.0986 for 2609 observed reflections.

Absorption, Circular Dichroism, and Luminescence Spectroscopy of Electrogenerated Delta-[Ru(bipy)(3)](+/0/)(-) and Delta-[Os(bipy)(3)](+/0/)(-) (bipy = 2,2'-Bipyridine)

The electronic absorption and circular dichroism (CD) spectra of the complexes produced by the one, two, and three electron reduction of Delta-[Ru(bipy)(3)](2+) and Delta-[Os(bipy)(3)](2+) are reported. The CD spectra give unequivocal proof that the added electrons are localized on individual bipiridine ligands and thus that the complexes are correctly formulated [M(bipy)(2)(bipy(-))](+), [M(bipy)(bipy(-))(2)](0), and [M(bipy(-))(3)](-). The absorption spectra of the triply reduced species [M(bipy(-))(3)](-) (M = Ru, Os) are compared to those of the Fe(II) and Ir(III) analogs. The luminescence spectra of the two triply reduced complexes [Ru(bipy(-))(3)](-) and [Os(bipy(-))(3)](-). are also presented. The MLCT luminescence found in the parent complexes is completely quenched and is replaced by a weak luminescence attributed to the pi(10) --> pi(7) transition of the (coordinated) [bipy](-) ion.